nVent Electric plc (NYSE:NVT) reported in-line earnings for the fourth quarter on Friday.The company posted quarterly earnings of 90 cents per share which met the analyst consensus estimate. The company reported quarterly sales of $1.067 billion which beat the analyst consensus estimate of $1.005 billion.nVent Electric said it sees FY2026 adjusted EPS of $4.00-$4.15, versus market estimates of $4.06. The company expects FY2026 sales of $4.477 billion-$4.594 billion, versus estimates of $4.426 billion.nVent ...

nVent Electric plc (NYSE:NVT) reported in-line earnings for the fourth quarter on Friday.The company posted quarterly earnings of 90 cents per share which met the analyst consensus estimate. The company reported quarterly sales of $1.067 billion which beat the analyst consensus estimate of $1.005 billion.nVent Electric said it sees FY2026 adjusted EPS of $4.00-$4.15, versus market estimates of $4.06. The company expects FY2026 sales of $4.477 billion-$4.594 billion, versus estimates of $4.426 billion.nVent ...

Core Insights - Hims & Hers Health's stock dropped 25% after the company announced it would cease selling its compounded semaglutide weight-loss pill, just days after its launch, due to legal action from Novo Nordisk [1][1][1] - Novo Nordisk has filed a lawsuit against Hims & Hers, seeking to permanently ban the sale of unapproved compounded drugs that infringe on its patents and is pursuing damages [1][1][1] - Hims & Hers has faced significant stock depreciation, losing over 60% of its value in the past 12 months, while Novo Nordisk's shares have decreased by approximately 40% during the same period [1][1][1] Company Developments - Hims & Hers announced the discontinuation of its compounded weight-loss pill, which was marketed as having the same active ingredient as Novo Nordisk's Wegovy, following legal threats from Novo Nordisk [1][1][1] - The lawsuit from Novo Nordisk is described by Hims & Hers as a "blatant attack" on Americans who rely on compounded medications, indicating the company's intent to continue advocating for access to these treatments [1][1][1] Industry Context - The FDA has indicated plans to restrict the use of GLP-1 active ingredients in compounded weight-loss medications, specifically mentioning Hims & Hers in its statement [1][1][1] - Eli Lilly is anticipated to receive FDA approval for its own weight-loss pill later this year, which could further impact competition in the weight-loss drug market [1][1][1]

When the beat changes, investors switch up their moves. Last week, they rushed to re-tune their portfolios. ...

Key Takeaways NBIS will report Q4 results Feb. 12, with the consensus implying a 44-cent loss and $232.2 million in revenue.Nebius is scaling its AI cloud with new platform releases and expanded global data center capacity.NBIS began contributions from Microsoft and Meta contracts in Q4, while facing heavy capex and supply woes.Nebius Group N.V. (NBIS) will report fourth-quarter 2025 results on Feb. 12, before market open.The Zacks Consensus Estimate for the bottom line for the to-be-reported quarter is peg ...

Software stocks mostly rebounded on Monday as Wall Street analysts pushed back against growing investor fears that artificial intelligence could disrupt the sector’s business models. Oracle (ORCL) shares jumped 10% after DA Davidson’s Gil Luria upgraded the stock to Buy from Neutral, citing optimism about the company’s OpenAI deal and pushing back against fears that AI would hurt its software business. "Software isn’t dead," Luria said in a note. "We believe companies will continue to pay for Oracle’s ...

Cango (NYSE: CANG), a Bitcoin (BTC) mining company, said it sold 4,451 BTC over the weekend, generating net proceeds of about $305 million as it moves to reduce leverage tied to a bitcoin-collateralized loan. The company said on Feb. 9 the transaction was settled in Tether’s USDT stablecoin, with the full amount used to pay down debt backed by its Bitcoin holdings. Related: Popular crypto company exits Bitcoin amid crash The move comes as mining economics remain volatile and reflects what the company de ...

Archer Aviation (NYSE: ACHR) is working toward commercializing a novel aircraft that could disrupt urban mobility for the better. This battery-powered craft, called Midnight, can seat four passengers (plus a pilot), is quieter and more sustainable than helicopters, and could save travelers hours in traffic by flying above gridlock. The company has been hatching this electric vertical takeoff and landing (eVTOL) for over seven years. And while at times it's made progress toward gaining regulatory approval ...

San Diego, California--(Newsfile Corp. - February 9, 2026) - The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Fermi Inc. (NASDAQ: FRMI): (i) common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with Fermi's October 2025 initial public offering ("IPO"); and/or (ii) securities between October 1, 2025 and December 11, 2025, both dates inclusive (the "Class Period"), have until Friday, March 6, 2026 to seek appointmen ...

WILMINGTON, Del., Feb. 9, 2026 /PRNewswire/ -- Synteq Digital ("Synteq"), a global leader in digital compute infrastructure and services, today announced it has closed a transformative strategic acquisition involving the operating assets of HMTech, a premier repair and maintenance business. The asset acquisition, together with the previously announced strategic real estate acquisition from Horizon Kinetics ("Horizon") and FRMO Corp. ("FRMO"), represents a major expansion of Synteq's vertically integrated s ...